EnteroMedics Company Profile (NASDAQ:ETRM)

About EnteroMedics (NASDAQ:ETRM)

EnteroMedics logoEnteroMedics Inc. (EnteroMedics) is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company's neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve. The Company's initial product is the Maestro Rechargeable System, which uses VBLOC therapy to limit the expansion of the stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The Company's VBLOC therapy is designed to block the gastrointestinal effects of the vagus nerve by replicating a vagotomy using high-frequency, low-energy electrical impulses to intermittently interrupt naturally occurring neural impulses on the vagus nerve between the brain and the digestive system.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ETRM
  • CUSIP: 29365M20
  • Web: www.enteromedics.com
Capitalization:
  • Market Cap: $29.98 million
  • Outstanding Shares: 6,906,000
Average Prices:
  • 50 Day Moving Avg: $4.88
  • 200 Day Moving Avg: $6.03
  • 52 Week Range: $1.75 - $30.41
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.59
  • P/E Growth: -4.54
Sales & Book Value:
  • Annual Revenue: $754,700.00
  • Price / Sales: 39.99
  • Book Value: $2.60 per share
  • Price / Book: 1.68
Profitability:
  • EBIDTA: ($22,170,000.00)
  • Net Margins: -3,088.74%
  • Return on Equity: -506.36%
  • Return on Assets: -171.80%
Debt:
  • Current Ratio: 5.62%
  • Quick Ratio: 5.16%
Misc:
  • Average Volume: 483,148 shs.
  • Beta: 3.04
  • Short Ratio: 4.36
 

Frequently Asked Questions for EnteroMedics (NASDAQ:ETRM)

What is EnteroMedics' stock symbol?

EnteroMedics trades on the NASDAQ under the ticker symbol "ETRM."

When did EnteroMedics' stock split? How did EnteroMedics' stock split work?

EnteroMedics shares reverse split on Friday, January 8th 2016. The 1-15 reverse split was announced on Wednesday, December 23rd 2015. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 7th 2016. An investor that had 100 shares of EnteroMedics stock prior to the reverse split would have 7 shares after the split.

How were EnteroMedics' earnings last quarter?

EnteroMedics Inc. (NASDAQ:ETRM) announced its quarterly earnings data on Tuesday, May, 16th. The company reported ($1.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.63) by $0.64. The company had revenue of $0.04 million for the quarter. EnteroMedics had a negative net margin of 3,088.74% and a negative return on equity of 506.36%. View EnteroMedics' Earnings History.

Where is EnteroMedics' stock going? Where will EnteroMedics' stock price be in 2017?

1 equities research analysts have issued 1-year price objectives for EnteroMedics' shares. Their forecasts range from $11.00 to $11.06. On average, they expect EnteroMedics' stock price to reach $11.03 in the next twelve months. View Analyst Ratings for EnteroMedics.

Who are some of EnteroMedics' key competitors?

Who are EnteroMedics' key executives?

EnteroMedics' management team includes the folowing people:

  • Dan W. Gladney, Chairman of the Board, President, Chief Executive Officer
  • Scott P. Youngstrom, Chief Financial Officer, Chief Compliance Officer
  • Naqeeb Ansari, Senior Vice President - Sales
  • Paul Hickey, Senior Vice President - Marketing and Reimbursement
  • Peter M. Delange, Senior Vice President - Operations and Business Development
  • Adrianus Donders, Senior Vice President - Research and Advanced Development
  • Katherine S. Tweden Ph.D., Senior Vice President - Research
  • Tonya Dowd, Vice President - Reimbursement
  • Gary D. Blackford, Director
  • Lori Courtney McDougal, Director

Who owns EnteroMedics stock?

EnteroMedics' stock is owned by many different of institutional and retail investors. Top institutional investors include NIHALANI RAJESH (38.70%). Company insiders that own EnteroMedics stock include Carl Goldfischer, Mark B Knudson and Peter M Delange. View Institutional Ownership Trends for EnteroMedics.

How do I buy EnteroMedics stock?

Shares of EnteroMedics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is EnteroMedics' stock price today?

One share of EnteroMedics stock can currently be purchased for approximately $4.37.


MarketBeat Community Rating for EnteroMedics (NASDAQ ETRM)
Community Ranking:  3.3 out of 5 (  )
Outperform Votes:  103 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  156
MarketBeat's community ratings are surveys of what our community members think about EnteroMedics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for EnteroMedics (NASDAQ:ETRM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.03 (152.40% upside)

Analysts' Ratings History for EnteroMedics (NASDAQ:ETRM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/25/2017Ladenburg Thalmann Financial ServicesReiterated RatingBuy$11.00LowView Rating Details
1/9/2017S&P Equity ResearchLower Price Target$17.19 -> $11.06N/AView Rating Details
6/9/2016Roth CapitalDowngradeBuy -> Neutral$3.00 -> $3.00N/AView Rating Details
11/10/2015Canaccord GenuityLower Price Target$37.50 -> $15.00N/AView Rating Details
7/20/2015Craig HallumLower Price TargetBuy$75.00 -> $30.00N/AView Rating Details
(Data available from 7/20/2015 forward)

Earnings

Earnings History for EnteroMedics (NASDAQ:ETRM)
Earnings by Quarter for EnteroMedics (NASDAQ:ETRM)
Earnings History by Quarter for EnteroMedics (NASDAQ ETRM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/16/2017Q1 2017($0.63)($1.27)$0.04 millionViewN/AView Earnings Details
3/7/2017Q4 2016($0.44)($2.65)$0.14 millionViewN/AView Earnings Details
11/10/2016Q3 2016($0.50)($0.17)$0.34 million$0.30 millionViewN/AView Earnings Details
8/4/2016Q216($0.75)($0.49)$0.19 million$0.28 millionViewN/AView Earnings Details
2/17/2016Q315($0.90)($0.95)$0.43 million$0.15 millionViewListenView Earnings Details
8/6/2015Q215($0.10)($0.10)$0.06 million$0.08 millionViewN/AView Earnings Details
2/18/2015Q414($0.10)($0.09)ViewN/AView Earnings Details
11/12/2014Q3 14($0.10)($0.08)ViewN/AView Earnings Details
8/7/2014Q2($0.10)($0.11)ViewListenView Earnings Details
4/30/2014Q1 14($0.10)($0.10)ViewN/AView Earnings Details
2/12/2014Q413($0.10)($0.11)ViewN/AView Earnings Details
10/31/2013Q313($0.11)($0.11)ViewN/AView Earnings Details
7/31/2013Q2 2013($0.13)($0.11)ViewN/AView Earnings Details
5/1/2013Q1 2013($0.13)($0.14)$0.10 millionViewN/AView Earnings Details
2/13/2013Q4 2012($0.14)($0.17)$0.36 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for EnteroMedics (NASDAQ:ETRM)
Current Year EPS Consensus Estimate: $-3.42 EPS
Next Year EPS Consensus Estimate: $-2.74 EPS

Dividends

Dividend History for EnteroMedics (NASDAQ:ETRM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for EnteroMedics (NASDAQ:ETRM)
Insider Ownership Percentage: 5.50%
Institutional Ownership Percentage: 3.54%
Insider Trades by Quarter for EnteroMedics (NASDAQ:ETRM)
Institutional Ownership by Quarter for EnteroMedics (NASDAQ:ETRM)
Insider Trades by Quarter for EnteroMedics (NASDAQ:ETRM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/25/2017Carl GoldfischerDirectorSell4,668$4.85$22,639.80View SEC Filing  
6/3/2016Peter M DelangeSVPBuy20,000$0.55$11,000.00View SEC Filing  
8/13/2015Mark B KnudsonCEOBuy303,000$0.25$75,750.00View SEC Filing  
6/19/2014Cathy FriedmanDirectorBuy11,800$1.70$20,060.00View SEC Filing  
1/8/2014Luke EvninDirectorSell556,585$2.50$1,391,462.50View SEC Filing  
2/27/2013Anthony P JanszDirectorBuy150,000$0.95$142,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for EnteroMedics (NASDAQ:ETRM)
Latest Headlines for EnteroMedics (NASDAQ:ETRM)
Source:
DateHeadline
americanbankingnews.com logoEnteroMedics Inc. (NASDAQ:ETRM) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - July 14 at 12:05 AM
americanbankingnews.com logoEnteroMedics Inc. (NASDAQ:ETRM) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - July 12 at 5:58 PM
finance.yahoo.com logoEnteroMedics Announces Affordable vBloc® Therapy Program for Weight Loss Patients
finance.yahoo.com - June 28 at 6:08 PM
prnewswire.com logoEnteroMedics Added to Russell Microcap® Index - PR Newswire (press release)
www.prnewswire.com - June 26 at 9:38 AM
finance.yahoo.com logoEnteroMedics Added to Russell Microcap® Index
finance.yahoo.com - June 26 at 9:38 AM
prnewswire.com logoEnteroMedics Announces vBloc Therapy to be Presented by ... - PR Newswire (press release)
www.prnewswire.com - June 21 at 6:35 PM
finance.yahoo.com logoEnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference
finance.yahoo.com - June 21 at 6:35 PM
finance.yahoo.com logoEdited Transcript of ETRM earnings conference call or presentation 7-Mar-17 4:00pm GMT
finance.yahoo.com - June 7 at 4:30 PM
finance.yahoo.com logoEnteroMedics, Inc. :ETRM-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
finance.yahoo.com - June 2 at 6:23 PM
streetinsider.com logoEnteroMedics (ETRM) Reports First vBloc Neurometabolic Therapy Implant at AMITA Health Adventist Medical Center Bolingbrook
www.streetinsider.com - May 31 at 5:01 PM
seekingalpha.com logoEnteroMedics announces first vBloc implant at Illinois hospital; shares up 3%
seekingalpha.com - May 31 at 10:43 AM
prnewswire.com logoEnteroMedics Announces First vBloc® Neurometabolic Therapy Implant at AMITA Health Adventist Medical Center ... - PR Newswire (press release)
www.prnewswire.com - May 31 at 9:31 AM
finance.yahoo.com logoEnteroMedics Announces First vBloc® Neurometabolic Therapy Implant at AMITA Health Adventist Medical Center Bolingbrook
finance.yahoo.com - May 31 at 9:31 AM
americanbankingnews.com logoEnteroMedics' (ETRM) "Buy" Rating Reaffirmed at Ladenburg Thalmann Financial Services
www.americanbankingnews.com - May 27 at 7:00 PM
americanbankingnews.com logoShort Interest in EnteroMedics Inc (ETRM) Rises By 2.6%
www.americanbankingnews.com - May 27 at 8:58 AM
americanbankingnews.com logoEnteroMedics Inc (ETRM) Director Carl Goldfischer Sells 4,668 Shares
www.americanbankingnews.com - May 26 at 4:46 PM
finance.yahoo.com logoEnteroMedics snaps up maker of obesity 'vest'
finance.yahoo.com - May 24 at 4:51 PM
seekingalpha.com logoEnteroMedics' (ETRM) CEO Dan Gladney Presents at Merger and Acquisition of BarioSurg, Inc. Conference (Transcript)
seekingalpha.com - May 23 at 4:47 PM
finance.yahoo.com logoEnteroMedics Announces the Acquisition of the Gastric Vest System
finance.yahoo.com - May 23 at 12:07 PM
seekingalpha.com logoEnteroMedics announces the acquisition of the Gastric Vest System; shares ahead 33% premarket
seekingalpha.com - May 23 at 8:51 AM
prnewswire.com logoEnteroMedics Announces First vBloc® Neurometabolic Therapy ... - PR Newswire (press release)
www.prnewswire.com - May 19 at 5:31 AM
finance.yahoo.com logoEnteroMedics Announces First vBloc® Neurometabolic Therapy Implant at McGuire Veterans Affairs Medical Center
finance.yahoo.com - May 18 at 10:21 AM
seekingalpha.com logoEnteroMedics' vBlock implanted in Richmond VA; shares ahead 13% premarket
seekingalpha.com - May 18 at 9:26 AM
americanbankingnews.com logoEnteroMedics Inc (ETRM) Issues Quarterly Earnings Results, Misses Estimates By $0.64 EPS
www.americanbankingnews.com - May 17 at 10:02 AM
finance.yahoo.com logoEdited Transcript of ETRM earnings conference call or presentation 16-May-17 12:30pm GMT
finance.yahoo.com - May 16 at 10:06 PM
feeds.benzinga.com logoMid-Afternoon Market Update: DXP Enterprises Gains On Strong Results; EnteroMedics Shares Plummet
feeds.benzinga.com - May 16 at 3:34 PM
finanznachrichten.de logoGainers & Losers Of May 15: CBMG, ETRM, ALNY, EGRX, ONCS...
www.finanznachrichten.de - May 16 at 11:51 AM
nasdaq.com logoMid-Morning Market Update: Markets Open Higher; Home Depot Earnings Beat Expectations
www.nasdaq.com - May 16 at 11:51 AM
finance.yahoo.com logoEnteroMedics Announces First Quarter 2017 Financial Results and Conference Call
finance.yahoo.com - May 16 at 11:51 AM
finance.yahoo.com logoEnteroMedics reports 1Q loss
finance.yahoo.com - May 16 at 11:51 AM
prnewswire.com logoEnteroMedics to Host First Quarter 2017 Conference Call - PR Newswire (press release)
www.prnewswire.com - May 11 at 5:41 PM
finance.yahoo.com logoEnteroMedics to Host First Quarter 2017 Conference Call
finance.yahoo.com - May 11 at 5:41 PM
americanbankingnews.com logoEnteroMedics (ETRM) Receiving Positive Media Coverage, Analysis Finds
www.americanbankingnews.com - May 3 at 6:26 PM
americanbankingnews.com logoEnteroMedics Inc (ETRM) Receives New Coverage from Analysts at Ladenburg Thalmann Financial Services
www.americanbankingnews.com - May 3 at 9:34 AM
americanbankingnews.com logoSomewhat Favorable News Coverage Somewhat Unlikely to Affect EnteroMedics (ETRM) Stock Price
www.americanbankingnews.com - April 27 at 11:04 PM
prnewswire.com logoEnteroMedics' vBloc® Neurometabolic Therapy Recognized at 2017 ... - PR Newswire (press release)
www.prnewswire.com - April 25 at 4:45 PM
finance.yahoo.com logoEnteroMedics' vBloc® Neurometabolic Therapy Recognized at 2017 ... - Yahoo Finance
finance.yahoo.com - April 24 at 8:27 AM
finance.yahoo.com logoEnteroMedics' vBloc® Neurometabolic Therapy Recognized at 2017 Edison Awards
finance.yahoo.com - April 24 at 8:27 AM
americanbankingnews.com logoEnteroMedics (ETRM) Given Coverage Optimism Score of 0.27
www.americanbankingnews.com - April 19 at 11:35 AM
americanbankingnews.com logo EnteroMedics Inc (ETRM) Receives Average Recommendation of "" from Brokerages
www.americanbankingnews.com - March 31 at 1:10 PM
streetinsider.com logoEnteroMedics (ETRM) Says vBloc Neurometabolic Therapy to be ... - StreetInsider.com
www.streetinsider.com - March 15 at 2:30 AM
seekingalpha.com logoEnteroMedics: A High Risk Short Opportunity - Seeking Alpha
seekingalpha.com - March 15 at 2:30 AM
finance.yahoo.com logoHere's Why EnteroMedics (ETRM) Stock Soared Today
finance.yahoo.com - March 14 at 4:24 PM
finance.yahoo.com logoENTEROMEDICS INC Financials
finance.yahoo.com - March 14 at 4:24 PM
finance.yahoo.com logoEnteroMedics' vBloc® Neurometabolic Therapy Featured on "The Doctors" TV Show
finance.yahoo.com - March 13 at 5:07 PM
biz.yahoo.com logoENTEROMEDICS INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 8 at 5:52 PM
baystreet.ca logoEnteroMedics (ETRM) Spikes Despite Q4 Loss
www.baystreet.ca - March 7 at 11:43 AM
us.rd.yahoo.com logoEnteroMedics Reports Fourth Quarter 2016 Financial Results
us.rd.yahoo.com - March 7 at 11:43 AM
biz.yahoo.com logoENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - March 7 at 11:43 AM
streetinsider.com logoEnteroMedics (ETRM) Regains Compliance With Nasdaq Listing Requirement
www.streetinsider.com - February 22 at 8:47 AM

Social

Chart

EnteroMedics (ETRM) Chart for Thursday, July, 20, 2017

This page was last updated on 7/20/2017 by MarketBeat.com Staff